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Abstract 
BACKGROUND: Cases of regressive melanomas represent a diagnostic and therapeutic challenge because time 
intervals between the presence of the primary tumour formation, the metastasis and the involution of the primary 
tumour may intertwine or occur at different times. The regression of cutaneous melanomas does not necessarily 
guarantee prevention from the development of locoregional or distant metastases. There are cases in which the 
prognosis of patients with the development of subsequent metastasis within regressive melanomas may be better 
depending on the number and location of metastases. 
CASE REPORT: We are presenting a 42-year-old patient with two timed removals of enlarged inguinal lymph 
nodes within one year, as the subsequent histological examination identified histopathological data for metastasis 
of melanoma. BRAF testing was positive for BRAF mutation. Within the anamnesis, it was further clear that the 
patient had an irritated melanocytic lesion in the lateral right thigh area, which over the time disappeared and 
shortly after that, the enlargement of locoregional lymph nodes has been noted.  
CONCLUSION: In the presented case prognosis and therapeutic options for treatment of patients with regression 
melanomas and subsequent development of lymph node metastasis have been discussed. Currently, there is no 
consentaneous opinion on the applicability of the early adjuvant therapy with targeted therapies or immunotherapy 
in patients with regressive and non-regressive type melanomas. We suggest and share the idea that early 
adjuvant therapy may be beneficial generally in patients with stage III melanomas. 
 
 
 
 
 
 
 
 
 
 
 
 
Dear Editor, 
 
We present a 42-year-old man who was 
hospitalised 1 year ago in a surgical department for 
enlargement of right inguinal lymph nodes. The lymph 
nodes were surgically resected. The histological 
evaluation found metastatic melanoma. BRAF testing 
revealed a wild type genotype. After a thorough 
examination and PET Scan, the primary tumour was 
not identified. Twelve months later, PET/CT of the 
whole body was performed due to an enlarged lymph 
node in the inguinal area (clinically/palpatory and 
ultrasound), and the scans confirmed a single 
enlarged, metabolically active, right/inguinal lymph 
node. Surgical removal of the enlarged lymph node 
from the proximal part of the right thigh was 
performed, below the inguinal fold (Figure 1a). The 
histological and immunohistochemical examination of 
the removed material identified a metastatic 
melanoma with infiltration through the lymph node 
capsule and perinodal soft tissues. The patient was 
visiting the Department of Dermatologic Surgery to 
clarify the diagnosis and to elucidate the further 
therapeutic regimen. During the clinical examination, a 
subungual pigmentation of the left foot’s thumb was 
observed (Figure 1c), which was subsequently 
identified as a post-traumatic subungual hematoma. 
Concomitantly, the presence of a melanocytic lesion 
with peripheral involution, suspicious for regression 
melanoma was found in the right femoral region 
(Figure 1b and 1d). The patient also reported the 
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presence (6 years earlier) of a mole in the right 
femoral area, which was traumatically irritated and 
treated with "silver water", resulting in a complete 
disappearance. Immediately afterwards, the patient 
observed repeated swellings localized in the right 
inguinal area, and in the first 2-3 years they were 
reversible, but subsequently, the tumor formation 
increased and became painful for which it was 
surgically removed and identified as lymph node 
metastasis from melanoma. A re-excision of the 
regression lesion is contemplated with a view to 
discussing the benefits of adjuvant therapy. 
 
Figure 1: a) Postoperative view after second surgical excision: 
surgical wound after inguinal lymph dissection to the right; b) and d) 
Clinical examination: melanocytic lesion with peripheral involution, 
clinically suspected for regression melanoma, located in the right 
femoral area; c) Subungual pigmentation of the left leg's thumb, 
identified as a post-traumatic subungual hematoma 
 
Cases of regressive melanomas represent a 
diagnostic and therapeutic challenge [1]. The greatest 
difficulty in data interpretation and subsequent 
diagnosis is caused by cases of patients with 
metastatic melanoma with complete regression of the 
primary lesion [2]. The time intervals between the 
presence or emergence of the primary tumour 
formation, the metastasis and the involution of the 
primary tumour may intertwine or occur at different 
times. This often confuses clinicians and is the reason 
for subsequent inadequate diagnostic and therapeutic 
steps. Interesting is the fact that 1) the regression of 
melanomas do not necessarily guarantee the 
prevention/protection from the development of 
locoregional or distant metastases [3] and that [2] the 
prognosis in some patients with metastasis within 
regressive melanoma may be better depending on the 
number and location of metastases (as in our case). 
In this regard, as important factors of major 
importance should be considered, on the one hand, 
primary tumour localisation, and, on the other, the 
location of metastasis development. 
As areas of involvement from the primary 
tumour, the head and neck are probably associated 
with worse prognosis due to the more complicated 
and complex lymphatic drainage system (as well as 
the thoracic area), which in turn, in the case of 
metastatic involvement, is further problems due to the 
need for lymph dissection. An example of a possible 
predictive significance/relevance link between location 
and the subsequent prognosis is the recently 
described in the literature metastasis of the internal 
organs (such as gastrointestinal) in patients with 
regression type melanomas compared with 
metastases in the inguinal area (as seen in our 
patient) [4]. In the case of inguinal metastatic 
involvement, better overall prognosis and survival 
should be expected compared to disseminated 
intestinal involvement, for example. We describe a 
young patient with primary regression of melanoma 
and subsequent development of locoregional 
(inguinal) metastases. A re-excision of the regression 
lesion, located in the right thigh area, is planned, with 
the possible benefit of subsequent therapy remaining 
open. 
New literature data suggest that early 
adjuvant therapy with targeted therapies or 
immunotherapy could provide greater benefits [5]. By 
definition, however, early adjuvant therapy is applied 
after resection of a primary melanoma, which opens 
the question of its applicability in the case of 
regression melanomas that are masked in the form of 
other skin diseases such as vitiligo [5], [6]. We 
propose an idea that early adjuvant therapy may be a 
key factor and also beneficial in patients with stage III 
melanomas in the case of completely eradicated 
metastatic tumours.  
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